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Fluorescence In Situ hybridization 
for Diagnosis of Whipple’s Disease in 
Formalin-Fixed Paraffin-embedded 
Tissue
Peter Braubach1‡, Torsten Lippmann1‡, Didier Raoult 2, Jean-Christophe Lagier 2,  
Ioannis Anagnostopoulos3, Steffen Zender 4, Florian Peter Länger 1†, Hans-Heinrich Kreipe1, 
Mark Philipp Kühnel 1† and Danny Jonigk 1*†
1 Institute of Pathology, Hannover Medical School (MHH), Hanover, Germany, 2 Aix Marseille University, CNRS, IRD, INSERM, 
AP-HM, URMITE, IHU Méditerranée Infection, Marseille, France, 3 Institute of Pathology, Charité Medical University Berlin, 
Berlin, Germany, 4 Department of Gastroenterology, Hepatology, and Endocrinology, Centre for Internal Medicine, Hannover 
Medical School (MHH), Hanover, Germany
Whipple’s disease (WD) is a rare chronic systemic infection with a wide range of clinical 
symptoms, routinely diagnosed in biopsies from the small intestine and other tissues 
by periodic acid–Schiff (PAS) diastase staining and immunohistological analysis with 
specific antibodies. The aim of our study was to improve the pathological diagnosis 
of WD. Therefore, we analyzed the potential of fluorescence in situ hybridization (FISH) 
for diagnosing WD, using a Tropheryma (T.) whipplei-specific probe. 19 formalin-fixed 
paraffin-embedded (FFPE) duodenal biopsy specimens of 12 patients with treated (6/12) 
and untreated (6/12) WD were retrospectively examined using PAS diastase staining, 
immunohistochemistry, and FISH. 20 biopsy specimens with normal intestinal mucosa, 
Helicobacter pylori, or mycobacterial infection, respectively, served as controls. We 
successfully detected T. whipplei in tissue biopsies with a sensitivity of 83% in untreated 
(5/6) and 40% in treated (4/10) cases of WD. In our study, we show that FISH-based 
diagnosis of individual vital T. whipplei in FFPE specimens is feasible and can be con-
sidered as ancillary diagnostic tool for the diagnosis of WD in FFPE material. We show 
that FISH not only detect active WD but also be helpful as an indicator for the efficiency 
of antibiotic treatment and for detection of recurrence of disease when the signal of PAS 
diastase and immunohistochemistry lags behind the recurrence of disease, especially if 
the clinical course of the patient and antimicrobial treatment is considered.
Keywords: Whipple’s disease, Tropheryma whipplei, fluorescence in situ hybridization, immunohistochemistry, 
formalin-fixed paraffin-embedded tissue
Abbreviations: CNS, central nervous system; Cy2, cyanine; Cy3, indocarbocyanine; DAB, 3,3′-diaminobenzidine; DAPI, 
4′,6-diamidin-2-phenylindol; EM, electron microscopy; FFPE, formalin-fixed paraffin-embedded; FISH, fluorescence in situ 
hybridization; H&E, hematoxylin and eosin; NCBI, national center for biotechnology information; PAS, periodic acid–Schiff 
reaction; qPCR, quantitative polymerase chain reaction; (r)RNA, (ribosomal) ribonucleic acid; T. whipplei, Tropheryma whip­
plei; WD, Whipple’s disease.
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inTrODUcTiOn
epidemiology, clinical Presentation, and 
Therapy
Whipple’s disease (WD) is a rare disease with an approxi-
mate prevalence of less than three cases per million people 
investigated in the general European population (data 
from Italy) (1, 2). It is caused by chronic systemic infec-
tion with the gram-positive bacterium Tropheryma whipplei  
(T. whipplei), which belongs to the group of Actinobacteria, one of 
the largest subgroups in the Bacteria domain. Related infectious 
organisms include Mycobacterium and Corynebacterium species 
(3). T. whipplei are non-motile and rod-shaped, about 1.4  µm 
in length and surrounded by a trilaminar cell wall containing 
glycans at the external membrane (4). Humans represent the 
only known host of T. whipplei and, most commonly, middle-
aged white men are affected (mean patient age is 55 years, 85% 
of patients are male). Patients with classic WD usually exhibit a 
wide range of non-specific gastrointestinal symptoms (e.g., diar-
rhea, abdominal pain, and malabsorption), ascites, weight loss, 
anemia, lymphadenopathy, and fever (1, 5, 6). WD is a multi-
systemic disease with manifestation in various extra-intestinal 
organs including the central nervous system (CNS) (10–50% of 
WD patients), the heart (endocarditis), joints (isolated arthritis, 
spondylodiscitis), the eye (uveitis), and lung (pneumonia) (7).
Notably, patients can also be asymptomatic carriers of 
T. whipplei, with up to 11% of the general European population 
testing positive in feces (data from Switzerland) (8, 9). T. whipplei  
is endemic in sewer workers and hyper-endemic in rural Senegal, 
as well as in families of patients and carriers (10, 11). Exposure 
to contaminated soil has been described as a possible way of 
infection with T. whipplei (1, 10, 12, 13); however, the most 
common infection transmission route is via the fecal-oral route. 
Close contact to carriers (1, 10, 11, 14) poor hygiene and living 
conditions (14), and the absence of toilets (11) are considered risk 
factors for infection with T. whipplei.
Inherited or acquired immunodeficiency is suspected to be 
required for the development of classic WD (15–17). The charac-
teristic duodenal histology, with marked infiltration of the intesti-
nal mucosa by macrophages, which can engulf T. whipplei but are 
incompetent to fully degrade them, can be explained by the lack of 
excessive local inflammation and an alternation in the phagocytic 
cell activation toward the phenotype of M2 macrophages (18).
Until the introduction of antibiotic treatment in the 1950s, 
WD was considered fatal due to progressive cachexia or involve-
ment of the CNS (1, 6, 18–20). Presently, WD is managed by 
an antibiotic regimen consisting of an initiation therapy with 
ceftriaxone followed by retention therapy with co-trimoxazole 
orally over the course of 1 year (1, 19, 20).
Diagnostic approaches
History of Diagnosis
George H. Whipple first described WD and suspected a bac-
terium as the causative agent in 1907. In 1949, intra-mucosal 
macrophages with a granular, periodic acid–Schiff (PAS) reac-
tion positive cytoplasm in the small intestine were described, 
suggesting degraded bacteria as a cause of WD. The actual bacterium, 
T. whipplei, was first detected by electron microscopy (EM) in 
1960 (21). In the 2000s, the first cultivation of T. whipplei was 
achieved by the centrifugation-shell-vial technique and a human 
fibroblast cell line (human erythroleukemia cell line) (22), and its 
whole genome was analyzed subsequently (3, 23).
Currently, a variety of techniques are applied for the diag-
nosis of WD, including conventional histopathology, immuno-
histochemistry, EM, PCR-based assays, and microbial culture.
Histopathologic Diagnosis
In most routine cases, duodenal biopsies represent the first step 
in diagnosing WD (24). The histological hallmark of WD is a 
mucosal infiltration of foamy macrophages containing large 
amounts of PAS positive, diastase-resistant particles in the lamina 
propria. Even if gastrointestinal symptoms are minimal or absent, 
biopsies of most patients show PAS positive macrophages in this 
location.
In a study of 48 cases of WD, von Herbay et al. (16) categorized 
four different phenotypes (types 1–4) of macrophages according 
to morphological characteristics, using PAS diastase staining 
(16). In WD, foamy PAS diastase positive macrophages are a 
distinct cytological feature in light and EM, which is not altered 
by routine processing of biopsies. Type 1 macrophages show a 
predominantly granular and intensively PAS positive cytoplasm, 
whereas in type 3 macrophages, the cytoplasm is described as 
diffusely granular with faint PAS positivity. Type 2 macrophages 
represent an intermediate morphology between types 1 and 3, 
with a grossly granular and intensively PAS positive cytoplasm 
with a diffuse or finely granular, faintly PAS positive background 
(Figure S1 in Supplementary Material). Type 4 macrophages show 
a predominantly foamy, only slightly PAS positive cytoplasm, or 
miss PAS positivity altogether (16).
In WD, progression and response to therapy can be roughly 
estimated by the morphological classification of the local mac-
rophage subtypes outlined above (25). von Herbay et  al. (16) 
showed that PAS positive type 1 macrophages predominate 
in patients before antibiotic treatment. During treatment, the 
number of type 2 macrophages increases and after about 1 year 
of therapy, type 3 macrophages dominate in the intestinal 
mucosa (16, 25). Consequently, PAS positive materials persist 
in macrophages, despite successful treatment and clinical cure 
(25). This incomplete elimination of T. whipplei in WD patients 
underpins the hypothesis put forward in several studies that a 
(local) immunodeficiency is required for the development of 
actual WD (18). It should be noted, however, that a negative PAS 
staining does not rule out WD.
In extra-intestinal disease, macrophages containing PAS 
positive, diastase-resistant inclusions can also be found in tissues 
and liquids such as liquor, the CNS, lymph nodes, synovial fluid, 
cardiac valves, or the bone marrow. Consequently, in cases with 
clinical suspicion of WD and negative duodenal biopsy, other 
anatomic sites should be investigated and potentially biopsied (7).
electron Microscopy
Using EM, T. whipplei was and can be successfully visualized in 
various stages of degradation in the extracellular spaces and in 
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macrophages of WD patients, for example in duodenal biopsies. 
However, due to its time consuming analysis, EM is no longer 
recommended as a diagnostic technique for WD (16, 21, 26).
Microbiological culture
Tropheryma whipplei can be cultured by the centrifugation-shell 
vial technique and a human fibroblast cell line (human erythro-
leukemia cell line); however, this approach is a time consuming 
method due to the generation time of 18  days of T. whipplei. 
Microbial culture has successfully been applied as method for the 
detection of T. whipplei from synovial fluids and feces of patients 
with WD (3, 22, 27, 28).
immunohistochemical staining
With the development of a T. whipplei specific polyclonal anti-
body, immunohistochemistry has become an important tool in 
the diagnostic algorithm of WD (29, 30). Immunohistochemistry 
represents a specific method for diagnosing WD even in patients 
with atypical manifestations and when PAS stains lacks specificity 
(16, 17, 24, 30).
Corresponding to PAS staining, anti-T. whipplei immuno-
histochemistry remains positive during the course of antibiotic 
treatment. The degraded remains of T. whipplei persist in the 
affected macrophages, and because the antibody links to epitopes 
in the wall of the bacteria, macrophages stain positive during and 
after treatment (1, 29, 30).
However, T. whipplei specific polyclonal antibody has to be 
produced in macrophages of rabbits and is not commercially 
available.
Polymerase chain reaction
Tropheryma whipplei-specific quantitative polymerase chain 
reaction (qPCR) is a reliable and specific method for diagnosing 
infections with T. whipplei, if confirmed by sequencing of multiple 
T. whipplei target genes to avoid false positive results. A singular 
positive result from gastrointestinal tissue may be the result of 
a simple colonization with T. whipplei. An actual WD should be 
suspected if saliva and feces specimens are both tested positive via 
qPCR and clinical symptoms are also present (31, 32). qPCR has 
also been described as a supportive diagnostic tool for the analysis 
of synovial fluid in suspected seronegative rheumatic diseases (33).
PCR analysis from cerebrospinal fluid is highly recommended 
in all WD cases, because asymptomatic T. whipplei infection of 
the CNS has been described in up to 40% of all patients with 
gastrointestinal manifestation of WD and represents a complica-
tion with a high mortality (1, 7, 17).
Bacterial species-specific Fluorescence 
In Situ hybridization
Bacterial species have previously been detected in situ by hybrid-
izing fluorescent oligonucleotide probes (of 15–30 base pairs in 
length) targeted against specific sequences in either the 16S or 
23S ribosomal RNA (rRNA) of bacteria (34–38). Fluorescence 
in situ hybridization (FISH) can be applied on cytological smears 
of fluids and formalin-fixed paraffin-embedded (FFPE) speci-
mens alike. rRNA is abundant (~105 copies per cell) and evenly 
distributed in the cytoplasm of bacteria, resulting in a positive 
staining of the whole bacterial cell by the respective FISH probe 
(34–40). Preamplification of specific rRNA sequences is not a pre-
requisite for this approach. Stained specimens can be analyzed by 
standard epifluorescence microscopy (34–40). The FISH probes 
can be individual designed and labeled, but a large amount of 
probes for diverse bacteria is also commercially available so far.
Fredricks et al. (5) investigated the localization of T. whip­
plei using FISH and confocal laser scanning microscopy in 
six intestinal and two lymph node specimens with WD and 
could describe the extracellular distribution of viable bacteria 
(5). Geissdorfer and colleagues (15) analyzed blood culture-
negative endocarditis in 255 patients using microbiological 
culture, PCR, FISH, conventional histopathology, and immu-
nohistochemistry: 16 cases tested positive for T. whipplei by 
PCR, while only one was positive by FISH (15). Audoly et al. 
(41) analyzed the impact of deglycosylation of a supposed 
T. whipplei biofilm on the discrepancies between diagnostic 
results in WD by FISH and immunofluorescence and hypoth-
esized that surface glycoconjugates have a protective role for 
T. whipplei and should therefore be removed to allow efficient 
bacterial detection (41).
These studies, which show that T. whipplei can in principle 
be successfully detected and visualized by FISH, lead us to the 
question of whether FISH-based diagnosis can be a reliable tool 
in routine FFPE samples in cases of suspected WD. To this end, 
we used a specific probe for T. whipplei and established a protocol 
for FFPE routine specimens in our lab.
MaTerials anD MeThODs
We identified 20 biopsies of confirmed WD from the archives 
of the Institute of Pathology, Hannover Medical School (MHH) 
and the Institute of Pathology, Charité Berlin. In these patients, 
the diagnosis of WD was based on conventional histopathologic 
criteria using the PAS stains and immunohistochemistry using 
the only non-commercially available and specific antibody 
described by Lepidi et  al. (30). Clinical data included age, sex, 
clinical manifestations, antimicrobial therapy, and course of 
the disease. These 20 biopsies were taken from 13 patients and 
belonged to 17 distinct cases (samples taken at the same time 
were summarized as a case). One sample (patient no. 7) was not 
sufficiently large for workup and was not further analyzed in this 
study. Serial sections were stained with hematoxylin and eosin 
(H&E) and PAS diastase stains, immunohistochemistry with 
the specific polyclonal (rabbit) anti-T. whipplei antibody and a 
species-specific anti-T. whipplei FISH probe.
The age of patients ranged from 37 to 70 years (mean: 54 years) 
and the age of the T. whipplei negative control group ranged from 
2 to 75  years (mean: 44  years). The male/female ratio was 5:1. 
Biopsies and surgical specimens came from the small intestine 
(n =  14), lymph nodes (n =  2), brain (n =  2), and the colon 
(n = 1). Previous antimicrobial therapy was reported in 6 patients 
and specimens from different time points before and after therapy 
where available from 3 patients (see Table 1).
Controls were arbitrarily selected: gastric biopsies with con-
firmed Helicobacter pylori infection (n =  7), duodenal biopsies 
TaBle 1 | Summary of patient data (age, sex, previous specific therapy of WD, and origin of tissue sample) including (consecutive) patient- and case numbers as well 
as laboratory IDs (patient no., case no., lab ID).
Patient no. case no. lab iD sex age Time between biopsies (Previous) therapy of WD sampling location
1 1 WD1 Male 57 – No Small intestinal mucosa
2 2 WD2 Male 64 – Yes Small intestinal mucosa
3 3 WD3 Male 50 – No Lymph node
4 4 WD4 Male 65 – No Small intestinal mucosa
5 5 WD5 Male 70 – Yes Small intestinal mucosa
6 6 WD6 Male 51 – Yes Brain
6 6 WD7 Male 51 Concurrent Yes Brain
8 7 WD9 Male 68 – No Small intestinal mucosa
9 8 WD10 Male 50 – Yes Small intestinal mucosa
9 9 WD11 Male 51 7 months Yes Small intestinal mucosa
9 9 WD12 Male 51 7 months Yes Mucosal membrane of the colon
10 10 WD18 Male 43 – Yes Small intestinal mucosa
10 11 WD13 Male 44 5 months Yes Small intestinal mucosa
10 11 WD14 Male 44 5 months Yes Small intestinal mucosa
10 12 WD15 Male 47 3 years Yes Small intestinal mucosa
11 13 WD16 Female 51 1 year Yes Small intestinal mucosa
11 14 WD17 Female 50 – Yes Small intestinal mucosa
12 15 WD19 Female 37 – No Lymph node
13 16 WD20 Male 70 – No Small intestinal mucosa
If two or more biopsies were available, or the timepoint of primary diagnosis of WD was known, the time interval between the biopsies (or between primary diagnosis and biopsy)  
is given. In one sample (patient no. 7), the remaining tissue did not suffice for workup in this study.
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with mycobacterial infection (n = 3), and duodenal biopsies with 
normal histology (n = 10); all of these samples were taken from 
the archives of the Institute of Pathology of MHH.
This study was approved by the local ethics committee of 
MHH (no. 3381-2016) and performed in accordance to the 
Helsinki declaration.
A paraffin block containing bacteria of Mycobacterium bovis, 
Staphylococcus aureus, Escherichia coli, and Aspergillus fumigatus 
(Cell Control Array Bacteria plus Fungi, Zytomed Systems, Berlin, 
Germany) served as additional control. All specimens had been 
formalin-fixed overnight and subsequently paraffin-embedded 
using established histopathological protocols. 4-µm thick tissue 
sections were stained with H&E and PAS diastase, respectively, 
following standard histopathological protocols.
immunohistochemical analysis
Immunohistochemical analysis was performed as previously 
described (30). Briefly, 3-µm thick sections were fixed to Super 
Frost slides (Thermo Scientific, USA), deparaffinized in xylene 
(2× 10  min) and rehydrated with graded ethanol (100, 85, 70, 
50, 20%, each for 2  min), ending in distilled water. The slides 
were then incubated in 3% hydrogen peroxide for 10  min and 
non-specific antigen binding sites were blocked by treating the 
slides with Reagent 1 (ZytoChemPlus Horse Radish Peroxidase 
(HRP) Polymer Kit, Zytomed Systems, Germany) for 5  min. 
Afterward, the slides were incubated with a primary antibody for 
1 h in a humidified chamber at room temperature. The primary 
antibody against T. whipplei, as described in “Whipple’s disease: 
Immunospecific and Quantitative Immunohistochemical Study 
of Intestinal Biopsy Specimens” by Lepidi et al. (30) and kindly 
provided by Dr. Didier Raoult (30), was used at a dilution of 
1:500. Unbound primary antibody was removed via rinsing with 
washing buffer for 5 min, before Reagent 2 (ZytoChemPlus HRP 
Polymer Kit, Zytomed Systems, Germany) was used for signal 
enhancement for 20 min. After rinsing with washing buffer, slides 
were incubated with the secondary antibody (ZytoChemPlus 
HRP Polymer Kit, Zytomed Systems, Germany) for 30  min. 
The slides were rinsed again with washing buffer and the bound 
antibodies were detected with 3,3′-Diaminobenzidine (DAB, 
DAB Substrate Kit High Contrast, Zytomed Systems, Germany). 
Finally, sections were rinsed with distilled water for 15 min, cel-
lular nuclei were stained for 2 min with haemalum, dehydrated 
in ascending Ethanol, and mounted with Eukitt media (Sigma-
Aldrich, Germany).
Fluorescence In Situ hybridization
Sections of 3  µm thickness were fixed on Super Frost slides 
(Thermo Scientific, USA) and air dried overnight. Sections were 
deparaffinized (60  min at 60°C, 2× 10  min 100% Xylene, and 
5 min 100% ethanol) and air dried. For dissolving components, 
FISH probes were preheated to hybridization temperature and 
10 µl of the indocarbocyanine (Cy3) labeled T. whipplei-specific 
probe (Biovisible, Netherlands) mixture was applied on each sec-
tion and covered airtight with a coverslip. After hybridization at 
52°C in a humid chamber for 18 h, sections were uncovered and 
washed at hybridization temperature in a wash-buffer (MCW 5, 
Biovisible, Netherlands) for 10  min. Sections were then rinsed 
with distilled water, air dried, and mounted with 4′,6-Diamidin-
2-phenylindol (DAPI) Dura Tec (Zytomed Systems, Germany) 
and a coverslip.
The sequence of the T. whipplei-specific probe (TAT TGC 
AAC CCT CTG TAC CA) had previously been described by 
Geissdorfer et al. in Ref. (15). Compared to all 16S rRNA entries in 
the blast NCBI (National Centre for Biotechnology Information), 
the T. whipplei-specific probe showed 100% coverage to T. whip­
plei with a five nucleotide mismatch to the next similar organ-
isms (Rhodanobacter strains, Dyella strains, Dokdonella strains, 
Tahibacter strains, and Frateuria strains) (42, 43).
TaBle 2 | Fluorescence in situ hybridization results compared to previous 
therapy and morphological classification of macrophages.
case no. (Previous) therapy Fish classification of macrophages
1 No Positive 3
3 No Negative 2
4 No Positive 2
7 No Positive 1
15 No Positive 1
16 No Positive 1
14 Yes Negative 2
2 Yes Positive 3
5 Yes Negative 3
6 Yes Negative 1
8 Yes Negative 2
9 Yes Negative 2
10 Yes Negative 1
11 Yes Positive 2
12 Yes Positive 3
13 Yes Positive 3
The fluorescence in situ hybridization results were described as “positive,” when one or 
more Tropheryma whipplei (T. whipplei) was found in the biopsy and “negative,” when 
T. whipplei was absent in the biopsy. Classification of macrophages: macrophages 
were classified with 1–3 regarding to the morphological characterization of periodic 
acid–Schiff diastase-positive macrophages described by von Herbay et al. (16). 
(Previous) therapy of Whipple’s disease (WD): “no” indicates that no specific  
WD therapy has started at time of biopsy, “yes” indicates that a specific  
antibiotic WD therapy has already been started at time of biopsy.
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Fluorescence In Situ hybridization 
combined with immunofluorescence
In order to correlate conventional immunohistochemical analy-
sis with FISH analysis, a combined immunofluorescence FISH 
analysis was performed.
First, FISH staining was carried out following our protocol 
described above. For the concomitant immunofluorescence 
staining, the primary antibody against T. whipplei was applied 
after rehydration with graded ethanol (100, 85, 70, 50, 20%, 
each for 2  min) finishing in distilled water, then incubating 
with 3% hydrogen peroxide for 10  min, and with Reagent 1 
(ZytoChemPlus HRP Polymer Kit, Zytomed Systems, Germany) 
for 5 min. Subsequently, sections were washed and incubated with 
a cyanine (Cy2)-labeled secondary antibody (ImmunoResearch 
Laboratories Inc., USA) for 30 min. After washing, sections were 
air dried and mounted with DAPI Dura Tec (Zytomed Systems, 
Germany) and a coverslip.
analysis, Visualization, and image 
Processing
Periodic acid–Schiff diastase staining was graded qualitatively, 
based on the morphological classification system described 
by von Herbay (16) and colleagues and semi quantitatively as 
described by Baisden et al. (16, 29).
The fluorescence slides were analyzed using an Olympus 
BX 51 epifluorescence microscope equipped with filters sensi-
tive for DAPI (Excitation peak: 358 nm, DNA-emission peak: 
461  nm and RNA-emission peak: 500  nm), Cy3 (Excitation 
peak: 550  nm, Emission peak: 570  nm), and Cy2 (Excitation 
peak: 492 nm, Emission peak: 510 nm) (Olympus corporation, 
Japan).
Photos were taken with a digital microscope (Keyence 
BZ9000 E, Osaka, Japan). Representative microphotographs 
were taken with filters for the detection of Cy3 (OP-66838 BZ 
TRITC Excitation wavelength: 540/25 Dichroic mirror wave-
length: 565 Absorption wavelength: 605/55), Cy2 (OP-66836 
BZ filter GFP-BP Excitation wavelength 470/40 Dichroic mirror 
wavelength: 495 Absorption wavelength: 535/50), and DAPI 
(OP-66834 BZ filter DAPI-BP Excitation wavelength 360/40 
Dichroic mirror wavelength: 400 Absorption wavelength 
460/50). Microphotographs were processed using the GNU 
Image Manipulation Program (GIMP, Version 2.8) on an IBM 
compatible PC running Windows 10.
resUlTs
routine Microscopy
Specimens of all 16 cases were morphologically classified using 
the system proposed by von Herbay et al. (16) using PAS dia-
stase staining (16). In six biopsies, macrophages predominantly 
showed granular intensive PAS positive cytoplasm (type 1), 
eight biopsies showed a grossly granular and intensive PAS 
positive cytoplasm and a diffusely granular, slightly PAS positive 
cytoplasm in the background (type 2), and in five biopsies mac-
rophages had a diffuse or finely granular, scarcely PAS positive 
cytoplasm (type 3) (Table 2).
immunohistochemical analysis
Specimens of all 16 cases with WD were positive for T. whipplei 
in immunohistochemical analysis, using the polyclonal (rabbit) 
anti-T. whipplei antibody described by Lepidi et al. (30) (Table 2). 
Staining was predominantly intracellular and congruent with 
foamy PAS diastase positive macrophages. In these cells, the 
pattern of antibody labeling was similar to the pattern of PAS 
diastase staining (Figure 1).
In all six patients with reported antimicrobial therapy, 
including three patients with longitudinal biopsies, immunohis-
tochemical analysis for T. whipplei was positive. Congruent with 
reported results, the staining intensity declined after treatment, 
but nevertheless remained positive in all samples.
No specific positive signal for T. whipplei was detected in the 
control specimens.
Fluorescence In Situ hybridization
To detect T. whipplei in the FFPE specimens, FISH was used on 
routine tissue sections of duodenal biopsies, lymph nodes, and 
brain tissue. These specimens showed an excellent morphological 
quality.
In nine cases, T. whipplei could successfully be visualized using 
the species-specific FISH probe. In the seven remaining cases, it 
was not possible to detect T. whipplei organisms (Figure 1; Table 2). 
As expected, all negative controls showed no signals with the 
species-specific FISH probe. In all seven cases having a diagnosed 
Helicobacter pylori infection, rod-shaped bacteria were detectable 
in the mucus of the gastric mucosa in the DAPI channel. These 
were negative for the T. whipplei-specific FISH probe, however.
In three cases of WD with an abundance of PAS diastase 
positive macrophages with a type 1 classification (according to 
von Herbay et al.) and positive immunostaining, the FISH probe 
FigUre 1 | Representative cases of Whipple’s disease with periodic acid-Schiff diastase staining (a,D,g,J) show accumulated macrophages intensely positive  
in periodic acid–Schiff diastase staining and with positive reaction in immunohistochemistry with a specific anti-Tropheryma whipplei (T. whipplei) antibody  
(B,e,h,K). Fluorescence in situ hybridization with a T. whipplei specific probe (c,F,i,l) shows differing numbers of intensely red-labeled bacteria ranging from dense 
aggregates (c) to sparse infiltrates of single bacteria (F,i), while some cases did not show bacteria in FISH (l). Presented cases are WD9 (a–c), WD1 (D–F), WD13 
(g–i), WD17 (J–l) (see also Table 2). The black bar is 30 µm. The white bar is 5 µm.
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visualized a prominent number of T. whipplei bacteria. In these 
patients, a specific antimicrobial therapy before sampling had not 
been reported (Figure 2).
In two other cases without antimicrobial therapy and a type 
2 and 3 classification [according to von Herbay et al. (16)] with 
a slightly positive immunolabeling signal, bacteria could easily 
be identified using FISH but were not distributed uniformly. In 
one case without reported antimicrobial therapy, no bacteria 
were detectable with FISH. The 3 FISH-positive patients who 
underwent a previous specific antibiotic treatment all showed no 
bacteria in the initial biopsy. Although, after a period of 2 years, 
the macrophages showed an intensive, granular PAS positive 
cytoplasm and a diffuse, more finely granular PAS positive cyto-
plasm in the background type 2 and 3 [according to von Herbay 
et al. (16)]; this pattern likely indicates an intestinal remission, 
and only/very few bacteria could be detected by FISH in the 
subsequent biopsy.
In the other cases, no bacteria could be detected via FISH, and 
most of these were classified as advanced WD with macrophages 
of type 2 or 3 [according to von Herbay et al. (16)].
FigUre 2 | Before specific antibiotic therapy, the majority of cases investigated in this series were positive in the Tropheryma whipplei (T. whipplei) specific 
fluorescence in situ hybridization (FISH). After specific therapy, the majority of cases were FISH-negative, remaining positivity may indicate persistence or  
recurrence of disease (see also Table 2).
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Tropheryma whipplei could be detected with FISH in 4 out of 
10 cases with a specific antibiotic treatment, possibly indicating 
persistence or reoccurrence of active WD (Figure 3).
combination of Fluorescence In Situ 
hybridization and immunofluorescence
Using a combination of T. whipplei-specific FISH and immuno-
fluorescence labeling, we could show that FISH and the specific 
antibody consistently label very similar areas in the tissues exam-
ined. However, some immunohistochemical signals were also 
found separate from FISH-positive bacteria. In contrast to FISH, 
antibody labeling was consistently found co-localizing with the 
PAS diastase-positive macrophages at the intracellular, and also 
at the extracellular compartments (Figure 4).
DiscUssiOn
In this study, we evaluated a species-specific FISH probe for the 
detection of T. whipplei, the bacterium causing WD, in FFPE 
tissue. We could detect T. whipplei in 56% (9/16) of the cases with 
clinically confirmed WD.
In the remaining cases, individual T. whipplei bacteria could 
not be observed. FISH negativity in cases positive by immu-
nohistochemistry and PAS diastase may be attributed to one 
or more of the following scenarios: low ribosome content of 
bacteria (pointing toward an inactive state), a suspected N- and 
O-glycoconjugates containing biofilm surrounding T. whipplei 
inside macrophages (impermeable for the FISH probe), dif-
ficulties of probes to permeate cell walls or the inaccessibility 
of specific target sites due to tertiary structures or the effect of 
ribosomal proteins (4, 34, 41, 44).
Fluorescence in  situ hybridization probes hybridize with 
bacteria, which contain high levels of rRNA, implying that 
hybridization depends on the metabolic activity of bacteria. 
A possible explanation for immunohistochemical positive 
and FISH-negative biopsies is the prior antibiotic treatment of 
WD. Due to the application of bacteriostatic and bactericidal 
antibiotics, such as ceftriaxone, bacteria are either arrested 
in their growth cycle or killed, both resulting in a decreased 
FigUre 3 | Fluorescent in situ hybridization (FISH) of Tropheryma whipplei (T. whipplei) may be a marker of disease recurrence. In one case, the first available 
biopsy (Bx1, taken after specific therapy) showed PAS diastase positive macrophages in the intestinal mucosa (a) and was positive in immunohistochemistry with 
the specific T. whipplei antibody (c). However, it was negative in FISH (e). One year after the biopsy, the patient presented with fever and arthralgia. A second 
biopsy (Bx2) was taken 4 weeks after onset of symptoms. This biopsy showed a reduction in PAS diastase positivity (B) and intensity of the specific 
immunohistochemistry (D) consistent with an effective therapy; however, in this biopsy, vital T. whipplei organisms could be detected in FISH (F).
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FigUre 4 | Combination of Tropheryma whipplei (T. whipplei) specific 
fluorescence in situ hybridization and fluorescence immunostaining with 
anti-T. whipplei antibody in an intestinal biopsy. 4′,6-Diamidin-2-phenylindol 
(DAPI) (a), T. whipplei-specific probe (Cy3) (B), anti- T. whipplei antibody with 
a fluorescence-labeled secondary antibody (Cy2) (c), overlay of 4′,6-DAPI,  
T. whipplei-specific probe (Cy3), and anti- T. whipplei antibody with a 
fluorescence-labeled secondary antibody (Cy2) (D). The white bar  
represents 5 µm.
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metabolic activity. This can result in an rRNA content well below 
the threshold required for detection by FISH leading to false 
negative results.
Considering the likely impact of prior antibiotic treatment 
on FISH results, we divided our study cohort into two groups, 
representing specimens from patients with antibiotic treatment 
and those without. T. whipplei bacteria were detectable by 
FISH in both samples from treated and untreated patients. In 
patients with no specific antibiotic therapy, 83% of all biopsies 
were positive in FISH analysis. In patients undergoing antibiotic 
therapy, 40% of cases were positive. Application of an antibiotic 
regimen is therefore a plausible explanation for negative FISH 
results; however, single bacteria could also be visualized in 40% 
of cases with antibiotic treatment. In all FISH-positive cases 
from patients undergoing antibiotic therapy, bacteria could be 
detected in the second biopsy with a time lapse of 5 months to 
2  years after initiation of therapy. This may represent a reac-
tivation, persistence, or reinfection after an initially sufficient 
treatment (41).
Another reason for the potentially low rRNA content of bac-
teria in FISH-negative cases may be the fact that most T. whipplei 
bacteria are phagocytized by macrophages in the lamina propria. 
These macrophages display a foamy and granular cytoplasm, 
which stains positive via PAS diastase, representing the phagocyt-
ized and degraded bacteria, which are also positive in specific 
immunohistochemistry.
The differential distribution of degraded and inactive bacteria 
inside vacuoles of macrophages and of metabolically active 
bacteria predominantly in the extracellular compartment 
has been described by Fredricks and colleagues (1, 5, 15, 29, 
30, 41). These authors also showed that a T. whipplei-specific 
FISH probe no longer hybridized in WD cases treated with 
RNAse, which leads to the assumption that enzymatic degra-
dation actually destroys the probe’s target. The distribution of 
T. whipplei antigens or dead bacteria inside macrophage vacu-
oles and metabolically active bacteria in the extracellular space 
was also confirmed by a study of Audoly et al. (41). This aspect 
is also supported by our findings in the combined T. whipplei-
specific FISH and immunofluorescence labeling, where 
signals of antibody stain and FISH did not fully colocalize. In 
addition, Audoly et al. (41) detected a N- and O-glykosylation 
surrounding T. whipplei cell material in unknown state of 
degradation within the PAS diastase-positive macrophages, 
suspecting a biofilm hindering the oligonucleotide probe to 
permeate (41).
The permeability of the cellular wall of bacteria for the oligo-
nucleotide probes (with a molecular weight of about 6,500 Da) 
in formalin-fixed specimen is not fully resolved; however, FISH 
analysis with oligonucleotide probes was successfully used in 
several previous studies including smears and tissue preparations 
from human and animals but also whole cell hybridization of 
bacteria (34, 35, 38, 45, 46). The T. whipplei species-specific probe 
was analyzed, was also successful used in three studies before (5, 
15, 41). Differences in the three-dimensional structure of the 
ribosome or the effect of ribosomal protein interactions could be 
reasons for negative results (44).
Perspectives
In order to verify our assumption that treated and inactive cases 
of WD are not detectable via FISH, a larger cohort of untreated 
cases of WD has to be investigated. Ideally, this would mean 
longitudinal studies of patients with WD before and after antibi-
otic treatment. By using multi-labeled FISH probes, it might be 
possible to increase signal intensity to allow detection of bacteria 
with a low content of rRNA and by this improving the overall 
sensitivity of the assay (47, 48).
Combination of immunohistological staining using species-
specific antibodies and FISH probes could allow new insights into 
the cellular composition of ongoing infection and distribution of 
bacteria in their natural habitat (5, 41).
In our study, we could show in 12 patients from routine prac-
tice that FISH has the potential to diagnose active WD in FFPE 
specimens and enables the direct visualization and detection of 
individual vital bacteria in the infected tissue (5, 6, 34, 38, 49, 
50). While sensitivity of FISH is not yet ideal, the commercially 
available FISH represents a valuable addition to the diagnostic kit 
and may be improved by the deglycolisation method proposed by 
Audoly et al. (41). FISH has value as an ancillary diagnostic tool, 
if used correctly. Our results show that FISH may be a helpful 
method to detect recurrence of disease after antibiotic treatment 
when the signal of PAS diastase and the specific immunohis-
tochemistry lags behind the recurrence of disease, especially if 
the clinical course of the patient and antimicrobial treatment is 
considered.
Fluorescence in  situ hybridization should not be used for a 
definite exclusion of WD but can visualize and resolve individual 
vital T. whipplei bacteria on formalin-fixed specimen of active 
WD. It therefore may be considered an indicator for the efficiency 
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of antibiotic treatment or a potential indicator of a reactivation or 
reinfection in the course of WD treatment.
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